drugset / Trial / NCT06890897
Esketamine Combined Pulsed Radiofrequency for Acute/Subacute Zoster-associated Trigeminal Neuralgia
Recruiting
174 enrolled
Beijing Tiantan Hospital
Beijing Ditan Hospital · collabBeijing Xiaotangshan Hospital · collabHengshui People's Hospital · collabThe First Hospital of Fangshan District,Beijing · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
To assess the 1-month effects and safety of esketamine combined PRF and standardized treatment to relieve pain in patients with acute/subacute zoster-related trigeminal neuralgia(ZRTN).
Timeline
- Start
- 2025-04-01
- Primary completion
- 2026-06-30
- Completion
- 2026-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Esketamine | Other / unclassified | 8 mg | Intravenous |